Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography

February 28, 2020 updated by: Fox Chase Cancer Center

Text for Health: Integrating Technology and Health Communication to Improve Health Outcomes (Part 2 of 2)

This pilot clinical trial studies how well technology and health communication works in improving health outcomes in patients scheduled for mammography screening. The Mobile Mammography Screening Program provides a vital health service and it is important that all women scheduled for an appointment show-up to be screened. Technology and health communication may help decrease no-show rates among patients scheduled for mammography screening.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

PRIMARY OBJECTIVES:

I. To decrease the mobile mammography unit no-show rate by sending text message appointment reminders to patients.

II. To assess the efficacy of the text message reminders at addressing the no-show rate by collecting satisfaction survey data from patients that received the texts and that came to their scheduled appointment.

OUTLINE:

Patients receive 1-2 text messages a few weeks before and 1 text message 24 hours before their mammography screening appointment. Patients also receive a phone call reminder as per standard practice.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19111
        • Fox Chase Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Appointment is at a participating location
  • Has a cell phone that can send and receive text messages
  • Agrees to receive the text messages
  • Can read either English or Spanish
  • Not yet sent text messages to 100 patients in community or corporate sites
  • Scheduled at least 1 week prior to the appointment date
  • PATIENTS FOR FOLLOW UP: come to their scheduled appointment
  • PATIENTS FOR FOLLOW UP: received the text message reminders
  • PATIENTS FOR FOLLOW UP: can read either English or Spanish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Health Services Research (text message reminder)
Patients receive 1-2 text messages a few weeks before and 1 text message 24 hours before their mammography screening appointment. Patients also receive a phone call reminder as per standard practice.
Other: Questionnaire Administration
Ancillary studies
Behavioral: Telephone-Based Intervention
Receive text message reminders

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in no-show rate pre- and post-intervention
Time Frame: Baseline to up to 1 year
The change (or lack of change) in the corporate sites? no-show rate will be compared to the change (or lack of change) in the community sites? no-show rate. Descriptive statistics will be used to describe the results.
Baseline to up to 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability of using text messaging as a reminder: survey
Time Frame: Up to 1 year
Descriptive statistics will be used to report the results of the satisfaction survey.
Up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fox Chase Cancer Center

Collaborators

National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Nestor Esnaola, Fox Chase Cancer Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 5, 2014

Primary Completion (ACTUAL)

October 28, 2014

Study Completion (ACTUAL)

October 1, 2017

Study Registration Dates

First Submitted

February 27, 2020

First Submitted That Met QC Criteria

February 28, 2020

First Posted (ACTUAL)

March 2, 2020

Study Record Updates

Last Update Posted (ACTUAL)

March 2, 2020

Last Update Submitted That Met QC Criteria

February 28, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB13858 (OTHER: Fox Chase Cancer Center)
  • P30CA006927 (U.S. NIH Grant/Contract)
  • NCI-2015-02088 (REGISTRY: CTRP (Clinical Trial Reporting Program))

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subject

Clinical Trials on Questionnaire Administration

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe